Wittington Ventures

Wittington Ventures is a Toronto-based venture capital firm that focuses on investing in companies at all stages of the start-up lifecycle. Established in 2019, it specializes in technology-oriented sectors, including e-commerce, retail, healthcare, and food. The firm prioritizes investments across North America and leverages its strong connections with well-known Canadian brands to support entrepreneurs and their ventures effectively. Through its strategic investments, Wittington Ventures aims to foster innovation and growth in the businesses it partners with.

Carley-Rose Horowitz

Associate

Qasim Mohammad

Partner

Jim Orlando

Managing Partner

Nick Taylor

Senior Associate

Darian Zigante

Senior Associate

22 past transactions

Grey Matter Neurosciences

Seed Round in 2025
Grey Matter Neurosciences is a neurotechnology company specializing in the development of innovative medical devices and drug-device combinations to address age-related brain disorders, with a primary focus on dementia. Their flagship technology is a portable ultrasound helmet, designed to non-invasively enhance brain function in seniors with Alzheimer's disease.

Noetik

Series A in 2024
Noetik is an AI-native biotechnology company focused on the discovery and development of cancer immunotherapies. Utilizing advanced machine learning techniques, Noetik's platform identifies new therapeutic targets and designs innovative treatments. By leveraging self-supervised learning and integrating human multimodal data, the company aims to enhance the effectiveness and personalization of cancer therapies, thereby improving patient outcomes in oncology.

Truvian Sciences

Venture Round in 2024
Truvian Sciences Inc, based in San Diego, California, specializes in developing automated diagnostic equipment that transforms the blood testing industry. Founded in 2015, the company offers a benchtop system designed to deliver lab-accurate results for a range of health tests. Its comprehensive wellness panel includes commonly ordered routine blood tests such as complete blood count, metabolic panel, and lipid panel, all processed from a single sample. Additionally, Truvian Sciences provides a software platform that enables healthcare practitioners to efficiently share test data with patients.

Abridge

Series C in 2024
Abridge Inc. is a healthcare technology company founded in September 1999, focused on enhancing communication in medical settings through innovative tools. The company utilizes generative AI to automate the transcription and summarization of patient-clinician conversations, converting these interactions into structured clinical notes in real-time. This platform integrates seamlessly with Electronic Health Record (EHR) systems, significantly reducing the need for manual note-taking. By generating clear and understandable summaries, Abridge improves patient comprehension of medical discussions and ensures that relevant documentation is accurately recorded in patient files. Additionally, the company emphasizes data security and patient privacy, adhering to healthcare regulations while providing a customizable interface that caters to individual patient needs.

Unlearn.AI

Series C in 2024
Unlearn.AI, Inc. is a biotechnology company that specializes in developing software tools for clinical research, focusing on improving diagnosis and treatment processes. Based in San Francisco, the company offers solutions such as Clinical Trial Design, which helps define inclusion criteria, endpoints, and study sizes; Synthetic Control Arms, which reduce or eliminate the necessity for concurrent control groups; and Subgroup Analysis, which identifies specific patient subgroups within trial results. Unlearn.AI has pioneered the TwinRCT solution, a digital twin service that leverages machine learning to enhance the efficiency and success rates of clinical trials. This innovative approach creates a prognostic digital twin for each patient, allowing for more precise estimations of treatment effects based on historical data. By integrating machine learning and biostatistics, Unlearn.AI aims to accelerate the clinical trial process, benefiting both patients and pharmaceutical sponsors.

Odaia

Series B in 2023
ODAIA is a company that has developed an AI-powered Customer Data Platform specifically for the Life Sciences industry. This innovative platform integrates process mining, customer journey mapping, and artificial intelligence to provide commercial insights and automate processes. By leveraging data analysis, ODAIA's solution enables pharmaceutical commercial teams to enhance personalized selling and ensure that therapeutics reach the patients who require them. The platform aims to streamline decision-making and improve the effectiveness of commercial strategies in the healthcare sector.

Unlearn.AI

Venture Round in 2023
Unlearn.AI, Inc. is a biotechnology company that specializes in developing software tools for clinical research, focusing on improving diagnosis and treatment processes. Based in San Francisco, the company offers solutions such as Clinical Trial Design, which helps define inclusion criteria, endpoints, and study sizes; Synthetic Control Arms, which reduce or eliminate the necessity for concurrent control groups; and Subgroup Analysis, which identifies specific patient subgroups within trial results. Unlearn.AI has pioneered the TwinRCT solution, a digital twin service that leverages machine learning to enhance the efficiency and success rates of clinical trials. This innovative approach creates a prognostic digital twin for each patient, allowing for more precise estimations of treatment effects based on historical data. By integrating machine learning and biostatistics, Unlearn.AI aims to accelerate the clinical trial process, benefiting both patients and pharmaceutical sponsors.

Abridge

Series A in 2022
Abridge Inc. is a healthcare technology company founded in September 1999, focused on enhancing communication in medical settings through innovative tools. The company utilizes generative AI to automate the transcription and summarization of patient-clinician conversations, converting these interactions into structured clinical notes in real-time. This platform integrates seamlessly with Electronic Health Record (EHR) systems, significantly reducing the need for manual note-taking. By generating clear and understandable summaries, Abridge improves patient comprehension of medical discussions and ensures that relevant documentation is accurately recorded in patient files. Additionally, the company emphasizes data security and patient privacy, adhering to healthcare regulations while providing a customizable interface that caters to individual patient needs.

goConfirm

Seed Round in 2022
goConfirm brings trust to online interactions everywhere. With a secure, verified ConfirmID, based on authentic government-issued ID and backed by state-of-the-art digital protocols, people around the world will have a secure, portable, reliable way to share and exchange their identity in everything they do online.

FOXTROT

Series C in 2022
Foxtrot Ventures, Inc., established in 2013 and headquartered in Chicago, Illinois, operates as a food and beverage delivery company. It offers a mobile application enabling users to shop for a wide range of products, including wine, spirits, groceries, ice cream, and essentials, which are then delivered to customers within an hour. Additionally, Foxtrot owns and operates grocery stores, further expanding its reach and offerings.

League

Series C in 2021
League is a technology company that focuses on transforming healthcare through a digital platform designed to enhance consumer experiences. It offers a healthcare consumer experience platform that facilitates personalized digital health solutions, enabling healthcare providers, partners, and employers to improve service delivery. By providing the necessary infrastructure for digital transformation, League allows these stakeholders to engage with consumers effectively and efficiently, helping them manage costs and improve health outcomes. The platform is aimed at making healthcare more accessible and tailored to individual needs, ultimately driving measurable results in the industry.

Arcaea

Series A in 2021
Arcaea is a biotechnology company dedicated to transforming the beauty and personal care industry by leveraging biology as a creative tool for self-expression. The company aims to develop innovative ingredients and product experiences through advanced technologies such as DNA sequencing, biological engineering, and fermentation. By focusing on the potential of biology, Arcaea seeks to create sustainable and eco-friendly ingredients, thereby offering the beauty industry new options that minimize environmental impact. Through its pioneering approach, Arcaea aspires to redefine the future of beauty by unlocking previously unattainable product capabilities.

Gatik

Series B in 2021
Gatik is a startup focused on developing autonomous technology for light and medium-duty trucks aimed at business-to-business short-haul logistics. Founded in 2017 and headquartered in Mountain View, California, the company specializes in artificial intelligence and automotive solutions tailored for the logistics sector. Gatik's software is designed for SAE Level 4 autonomous commercial vehicles, including trucks and vans in Classes 3 to 7. This technology facilitates middle-mile logistics, allowing customers to efficiently manage scheduled deliveries and optimize their supply chain operations.

Motif

Series B in 2021
Motif develops plant-based food products designed to produce healthy food using genetic engineering and fermentation. Their food technologies enable CPG companies to develop plant-based alternatives that have the same meaty taste, appearance, and texture as their animal counterparts. They offer bioprocessing services, finished products, and food services.

Truvian Sciences

Series C in 2021
Truvian Sciences Inc, based in San Diego, California, specializes in developing automated diagnostic equipment that transforms the blood testing industry. Founded in 2015, the company offers a benchtop system designed to deliver lab-accurate results for a range of health tests. Its comprehensive wellness panel includes commonly ordered routine blood tests such as complete blood count, metabolic panel, and lipid panel, all processed from a single sample. Additionally, Truvian Sciences provides a software platform that enables healthcare practitioners to efficiently share test data with patients.

FOXTROT

Series B in 2021
Foxtrot Ventures, Inc., established in 2013 and headquartered in Chicago, Illinois, operates as a food and beverage delivery company. It offers a mobile application enabling users to shop for a wide range of products, including wine, spirits, groceries, ice cream, and essentials, which are then delivered to customers within an hour. Additionally, Foxtrot owns and operates grocery stores, further expanding its reach and offerings.

Gatik

Series A in 2020
Gatik is a startup focused on developing autonomous technology for light and medium-duty trucks aimed at business-to-business short-haul logistics. Founded in 2017 and headquartered in Mountain View, California, the company specializes in artificial intelligence and automotive solutions tailored for the logistics sector. Gatik's software is designed for SAE Level 4 autonomous commercial vehicles, including trucks and vans in Classes 3 to 7. This technology facilitates middle-mile logistics, allowing customers to efficiently manage scheduled deliveries and optimize their supply chain operations.

Nurx

Series C in 2020
Nurx Inc. is a digital healthcare company that operates a mobile health platform, providing access to a variety of everyday medications, including contraceptives, travel medications, and prescriptions for conditions such as migraines and dermatological issues. Founded in 2015 and based in San Francisco, Nurx offers services that include doctor prescription reviews and at-home testing, such as Home HPV Screening for cervical cancer risk assessment. By allowing users to request medications and manage refills without the need for in-person visits, Nurx aims to empower individuals, particularly women, to take control of their health in a transparent and judgment-free environment. The company serves residents across multiple states, ensuring convenient and affordable healthcare solutions tailored to their needs.

Contentful

Series E in 2020
Contentful GmbH, established in 2011, is a technology company headquartered in Berlin, Germany, with additional offices in San Francisco and Denver. It specializes in developing a cloud-based content management platform, Contentful, designed to streamline digital experiences for businesses. Contentful enables companies to create, manage, and distribute content across multiple channels, including web and mobile applications, at a faster pace and larger scale than traditional CMS solutions. It unifies content in a single hub, structures it for use in any digital channel, and integrates seamlessly with other tools through open APIs. Contentful serves a diverse range of clients, including 30% of the Fortune 500 and prominent brands like Chanel, Shopify, and BP.

FOXTROT

Series A in 2020
Foxtrot Ventures, Inc., established in 2013 and headquartered in Chicago, Illinois, operates as a food and beverage delivery company. It offers a mobile application enabling users to shop for a wide range of products, including wine, spirits, groceries, ice cream, and essentials, which are then delivered to customers within an hour. Additionally, Foxtrot owns and operates grocery stores, further expanding its reach and offerings.

League

Corporate Round in 2019
League is a technology company that focuses on transforming healthcare through a digital platform designed to enhance consumer experiences. It offers a healthcare consumer experience platform that facilitates personalized digital health solutions, enabling healthcare providers, partners, and employers to improve service delivery. By providing the necessary infrastructure for digital transformation, League allows these stakeholders to engage with consumers effectively and efficiently, helping them manage costs and improve health outcomes. The platform is aimed at making healthcare more accessible and tailored to individual needs, ultimately driving measurable results in the industry.

League

Series B in 2018
League is a technology company that focuses on transforming healthcare through a digital platform designed to enhance consumer experiences. It offers a healthcare consumer experience platform that facilitates personalized digital health solutions, enabling healthcare providers, partners, and employers to improve service delivery. By providing the necessary infrastructure for digital transformation, League allows these stakeholders to engage with consumers effectively and efficiently, helping them manage costs and improve health outcomes. The platform is aimed at making healthcare more accessible and tailored to individual needs, ultimately driving measurable results in the industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.